Caryl E. Sortwell, Ph.D. - Publications

Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Parkinson's disease therapeutics

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Stoll AC, Kemp CJ, Patterson JR, Howe JW, Steece-Collier K, Luk KC, Sortwell CE, Benskey MJ. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Neurobiology of Disease. 106411. PMID 38228253 DOI: 10.1016/j.nbd.2024.106411  0.319
2024 Patterson JR, Kochmanski J, Stoll AC, Kubik M, Kemp CJ, Duffy MF, Thompson K, Howe JW, Cole-Strauss A, Kuhn NC, Miller KM, Nelson S, Onyekpe CU, Beck JS, Counts SE, ... ... Sortwell CE, et al. Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. Npj Parkinson's Disease. 10: 7. PMID 38172128 DOI: 10.1038/s41531-023-00620-y  0.843
2023 Collier TJ, Begg L, Stancati JA, Mercado NM, Sellnow RC, Sandoval IM, Sortwell CE, Steece-Collier K. Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine. Experimental Neurology. 114522. PMID 37640098 DOI: 10.1016/j.expneurol.2023.114522  0.818
2023 Boyd SL, Kuhn NC, Patterson JR, Stoll AC, Zimmerman SA, Kolanowski MR, Neubecker JJ, Luk KC, Ramsson ES, Sortwell CE, Bernstein AI. Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 37607008 DOI: 10.1093/toxsci/kfad086  0.791
2023 Stoll AC, Kemp CJ, Patterson JR, Kubik M, Kuhn N, Benskey M, Duffy MF, Luk K, Sortwell CE. Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model. Research Square. PMID 37205534 DOI: 10.21203/  0.699
2023 Caulfield ME, Vander Werp MJ, Stancati JA, Collier TJ, Sortwell CE, Sandoval IM, Manfredsson FP, Steece-Collier K. Downregulation of striatal Ca1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age. Neurobiology of Disease. 181: 106111. PMID 37001610 DOI: 10.1016/j.nbd.2023.106111  0.823
2022 Fischer DL, Auinger P, Goudreau JL, Paumier KL, Cole-Strauss A, Kemp CJ, Lipton JW, Sortwell CE. rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease. Frontiers in Neurology. 13: 1053591. PMID 36468063 DOI: 10.3389/fneur.2022.1053591  0.776
2022 Patterson JR, Cole-Strauss A, Kuhn N, Mercier C, Kochmanski J, Gerlach JA, LeVeque RM, Neugebauer KA, Conner KN, Gomez J, Hennes MG, Thompson KE, Rytlewski DL, Bigwood CC, Scharmen A, ... ... Sortwell CE, et al. Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling. Journal of Visualized Experiments : Jove. PMID 35815999 DOI: 10.3791/64008  0.53
2022 Patterson JR, Hirst WD, Howe JW, Russell CP, Cole-Strauss A, Kemp CJ, Duffy MF, Lamp J, Umstead A, Kubik M, Stoll AC, Vega IE, Steece-Collier K, Chen Y, Campbell AC, ... ... Sortwell CE, et al. Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61. PMID 35610264 DOI: 10.1038/s41531-022-00322-x  0.825
2022 Sossi V, Patterson JR, McCormick S, Kemp CJ, Miller KM, Stoll AC, Kuhn N, Kubik M, Kochmanski J, Luk KC, Sortwell CE. Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35524682 DOI: 10.1002/mds.29051  0.35
2022 Jaehne EJ, Kent JN, Antolasic EJ, Wright BJ, Spiers JG, Creutzberg KC, De Rosa F, Riva MA, Sortwell CE, Collier TJ, van den Buuse M. Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory. Translational Psychiatry. 12: 93. PMID 35256586 DOI: 10.1038/s41398-022-01858-5  0.742
2021 Sortwell CE, Hacker ML, Fischer DL, Konrad PE, Davis TL, Neimat JS, Wang L, Song Y, Mattingly ZR, Cole-Strauss A, Lipton JW, Charles PD. BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation : Journal of the International Neuromodulation Society. PMID 34288271 DOI: 10.1111/ner.13504  0.617
2021 Howe JW, Sortwell CE, Duffy MF, Kemp CJ, Russell CP, Kubik M, Patel P, Luk KC, El-Agnaf OMA, Patterson JR. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein. Parkinsonism & Related Disorders. 89: 41-47. PMID 34218047 DOI: 10.1016/j.parkreldis.2021.06.010  0.639
2021 Miller KM, Mercado NM, Sortwell CE. Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor. Npj Parkinson's Disease. 7: 35. PMID 33846345 DOI: 10.1038/s41531-021-00179-6  0.357
2021 Landeck N, Conti Mazza M, Duffy M, Bishop C, Sortwell CE, Cookson MR. Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease. Journal of Visualized Experiments : Jove. PMID 33682858 DOI: 10.3791/62128  0.765
2021 Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, et al. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. Jci Insight. 6. PMID 33682798 DOI: 10.1172/jci.insight.135633  0.812
2021 Miller KM, Patterson JR, Kochmanski J, Kemp CJ, Stoll AC, Onyekpe CU, Cole-Strauss A, Steece-Collier K, Howe JW, Luk KC, Sortwell CE. Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33472823 DOI: 10.1523/JNEUROSCI.1952-20.2020  0.822
2020 Fischer DL, Auinger P, Goudreau JL, Cole-Strauss A, Kieburtz K, Elm JJ, Hacker ML, Charles PD, Lipton JW, Pickut BA, Sortwell CE. BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33215284 DOI: 10.1007/s13311-020-00965-9  0.596
2020 Mercado NM, Stancati JA, Sortwell CE, Mueller RL, Boezwinkle SA, Duffy MF, Fischer DL, Sandoval IM, Manfredsson FP, Collier TJ, Steece-Collier K. The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats. Neurobiology of Disease. 105175. PMID 33188920 DOI: 10.1016/j.nbd.2020.105175  0.827
2020 Gezer AO, Kochmanski J, VanOeveren SE, Cole-Strauss A, Kemp CJ, Patterson JR, Miller KM, Kuhn NC, Herman DE, McIntire A, Lipton JW, Luk KC, Fleming SM, Sortwell CE, Bernstein AI. Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Neurobiology of Disease. 104947. PMID 32422283 DOI: 10.1016/J.Nbd.2020.104947  0.824
2020 Steece-Collier K, Collier TJ, Lipton JW, Stancati JA, Winn ME, Cole-Strauss A, Sellnow R, Conti MM, Mercado NM, Nillni EA, Sortwell CE, Manfredsson FP, Bishop C. Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in fisher 344 vs. Lewis hemiparkinsonian rats. Experimental Neurology. 113327. PMID 32387398 DOI: 10.1016/J.Expneurol.2020.113327  0.818
2020 Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, Collier TJ, Sortwell CE, West AR, Manfredsson FP. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32238479 DOI: 10.1523/Jneurosci.2936-19.2020  0.846
2019 Patterson JR, Duffy MF, Kemp CJ, Howe JW, Collier TJ, Stoll AC, Miller KM, Patel P, Levine N, Moore DJ, Luk KC, Fleming SM, Kanaan NM, Paumier KL, El-Agnaf OMA, ... Sortwell CE, et al. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Neurobiology of Disease. 104525. PMID 31276792 DOI: 10.1016/J.Nbd.2019.104525  0.828
2019 Collier TJ, Sortwell CE, Mercado NM, Steece-Collier K. Cell therapy for Parkinson's disease: Why it doesn't work every time. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31234239 DOI: 10.1002/Mds.27742  0.846
2019 Patterson JR, Polinski NK, Duffy MF, Kemp CJ, Luk KC, Volpicelli-Daley LA, Kanaan NM, Sortwell CE. Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo. Journal of Visualized Experiments : Jove. PMID 31205308 DOI: 10.3791/59758  0.798
2019 Steece-Collier K, Stancati JA, Collier NJ, Sandoval IM, Mercado NM, Sortwell CE, Collier TJ, Manfredsson FP. Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31002755 DOI: 10.1002/Mds.27695  0.825
2018 Fischer DL, Sortwell CE. BDNF provides many routes toward STN DBS-mediated disease modification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30440081 DOI: 10.1002/Mds.27535  0.821
2018 Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luke Fischer D, Stoll AC, Sortwell CE. Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease. Frontiers in Neuroscience. 12: 621. PMID 30233303 DOI: 10.3389/Fnins.2018.00621  0.819
2018 Raghunathan R, Polinski NK, Klein JA, Hogan JD, Shao C, Khatri K, Leon DR, McComb ME, Manfredsson FP, Sortwell CE, Zaia J. Glycomic and Proteomic changes in aging brain nigrostriatal pathway. Molecular & Cellular Proteomics : McP. PMID 29915149 DOI: 10.1074/Mcp.Ra118.000680  0.451
2018 Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, ... Sortwell CE, et al. Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. Journal of Neuroinflammation. 15: 169. PMID 29843738 DOI: 10.1186/S12974-018-1202-9  0.756
2018 Fischer DL, Auinger P, Goudreau JL, Paumier KL, Cole-Strauss A, Kemp CJ, Lipton JW, Sortwell CE. Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease. Parkinsonism & Related Disorders. PMID 29759928 DOI: 10.1016/J.Parkreldis.2018.05.003  0.808
2018 Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer LD, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, ... Sortwell CE, et al. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. Journal of Neuroinflammation. 15: 129. PMID 29716614 DOI: 10.1186/S12974-018-1171-Z  0.812
2018 Benskey MJ, Sellnow RC, Sandoval IM, Sortwell CE, Lipton JW, Manfredsson FP. Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity. Frontiers in Molecular Neuroscience. 11: 36. PMID 29497361 DOI: 10.3389/Fnmol.2018.00036  0.708
2018 Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, Froula J, Duffy MF, Lee VM, Martinez TN, Dave KD. Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. Journal of Parkinson's Disease. PMID 29400668 DOI: 10.3233/Jpd-171248  0.796
2017 Fischer DL, Manfredsson FP, Kemp CJ, Cole-Strauss A, Lipton JW, Duffy MF, Polinski NK, Steece-Collier K, Collier TJ, Gombash SE, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression. Scientific Reports. 7: 16356. PMID 29180681 DOI: 10.1038/S41598-017-16690-X  0.818
2017 Fischer DL, Manfredsson FP, Sortwell CE. Can STN DBS protect both nigral somata and innervation of the striatum? Annals of Neurology. PMID 28985650 DOI: 10.1002/Ana.25064  0.806
2017 Kanaan NM, Sellnow RC, Boye SL, Coberly B, Bennett A, Agbandje-McKenna M, Sortwell CE, Hauswirth WW, Boye SE, Manfredsson FP. Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS. Molecular Therapy. Nucleic Acids. 8: 184-197. PMID 28918020 DOI: 10.1016/J.Omtn.2017.06.011  0.66
2017 Collier TJ, Srivastava KR, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M, Havas D, Rochet JC, Liu F, Jock K, de Oliveira P, Stirtz GL, Dettmer U, Sortwell CE, Feany MB, et al. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiology of Disease. PMID 28711409 DOI: 10.1016/J.Nbd.2017.07.007  0.788
2017 Fischer DL, Kemp CJ, Cole-Strauss A, Polinski NK, Paumier KL, Lipton JW, Steece-Collier K, Collier TJ, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Employs TrkB Signaling for Neuroprotection and Functional Restoration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607168 DOI: 10.1523/Jneurosci.2060-16.2017  0.819
2017 Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. Alpha-Synuclein mRNA Is Not Increased. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28522034 DOI: 10.1016/J.Ymthe.2017.04.018  0.765
2016 Polinski NK, Manfredsson FP, Benskey MJ, Fischer DL, Kemp CJ, Steece-Collier K, Sandoval IM, Paumier KL, Sortwell CE. Impact of age and vector construct on striatal and nigral transgene expression. Molecular Therapy. Methods & Clinical Development. 3: 16082. PMID 27933309 DOI: 10.1038/Mtm.2016.82  0.807
2016 Fischer DL, Gombash SE, Kemp CJ, Manfredsson FP, Polinski NK, Duffy MF, Sortwell CE. Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson's Disease. Methods in Molecular Biology (Clifton, N.J.). 1382: 367-82. PMID 26611600 DOI: 10.1007/978-1-4939-3271-9_26  0.812
2015 Divito CB, Steece-Collier K, Case DT, Williams SP, Stancati JA, Zhi L, Rubio ME, Sortwell CE, Collier TJ, Sulzer D, Edwards RH, Zhang H, Seal RP. Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14983-99. PMID 26558771 DOI: 10.1523/Jneurosci.2124-15.2015  0.817
2015 Fischer DL, Collier TJ, Cole-Strauss A, Wohlgenant SL, Lipton JW, Steece-Collier K, Manfredsson FP, Kemp CJ, Sortwell CE. High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. Plos One. 10: e0133957. PMID 26222442 DOI: 10.1371/Journal.Pone.0133957  0.833
2015 Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier K, Kemp CJ, Celano S, Schulz E, Sandoval IM, Fleming S, Dirr E, Polinski NK, Trojanowski JQ, ... ... Sortwell CE, et al. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Disease. 82: 185-199. PMID 26093169 DOI: 10.1016/J.Nbd.2015.06.003  0.816
2015 Kanaan NM, Collier TJ, Cole-Strauss A, Grabinski T, Mattingly ZR, Winn ME, Steece-Collier K, Sortwell CE, Manfredsson FP, Lipton JW. The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes. Plos One. 10: e0127768. PMID 25992874 DOI: 10.1371/Journal.Pone.0127768  0.802
2015 Collier TJ, O'Malley J, Rademacher DJ, Stancati JA, Sisson KA, Sortwell CE, Paumier KL, Gebremedhin KG, Steece-Collier K. Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration. Neurobiology of Disease. 77: 191-203. PMID 25771169 DOI: 10.1016/J.Nbd.2015.03.005  0.839
2015 Paumier KL, Sortwell CE, Madhavan L, Terpstra B, Daley BF, Collier TJ. Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system. Experimental Neurology. 266: 11-21. PMID 25681575 DOI: 10.1016/J.Expneurol.2015.02.005  0.825
2015 Polinski NK, Gombash SE, Manfredsson FP, Lipton JW, Kemp CJ, Cole-Strauss A, Kanaan NM, Steece-Collier K, Kuhn NC, Wohlgenant SL, Sortwell CE. Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiology of Aging. 36: 1110-20. PMID 25457558 DOI: 10.1016/J.Neurobiolaging.2014.07.047  0.802
2015 Paumier KL, Sortwell CE, Madhavan L, Terpstra B, Celano SL, Green JJ, Imus NM, Marckini N, Daley B, Steece-Collier K, Collier TJ. Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 874-83. PMID 25267343 DOI: 10.1038/Npp.2014.262  0.833
2015 Polinski NK, Congdon L, Luke Fischer D, Manfredsson FP, Benskey M, Kemp C, Kuhn NC, Cole-Strauss A, Steece-Collier K, Paumier KL, Lipton JW, Sortwell CE. 715. Impact of Aging on Recombinant Adeno-Associated and Lentiviral Vector Transduction Efficiency in the Rat Nigrostriatal and Striatonigral Systems Molecular Therapy. 23: S285. DOI: 10.1016/S1525-0016(16)34324-6  0.815
2015 Sellnow RC, Steece-Collier K, Kanaan NM, Sortwell CE, Collier TJ, Cole-Strauss A, Lipton JW, Manfredsson FP. 709. rAAV-Mediated Regulation of Striatal Nurr1 Expression Alters Development and Severity of Levodopa-Induced Dyskinesias in the 6-OHDA Rat Model of Parkinson's Disease Molecular Therapy. 23: S282-S283. DOI: 10.1016/S1525-0016(16)34318-0  0.83
2015 Polinski N, Gombash S, Kemp C, Kuhn N, Cole-Strauss A, Wohlgenant S, Kanaan N, Steece-Collier K, Lipton J, Manfredsson F, Sortwell C. Decreased viral vector transducibility in the aged rat midbrain Experimental Gerontology. 68: 102. DOI: 10.1016/J.Exger.2015.01.032  0.791
2014 Gombash SE, Manfredsson FP, Mandel RJ, Collier TJ, Fischer DL, Kemp CJ, Kuhn NM, Wohlgenant SL, Fleming SM, Sortwell CE. Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. Gene Therapy. 21: 682-93. PMID 24807806 DOI: 10.1038/Gt.2014.42  0.827
2013 Gombash SE, Manfredsson FP, Kemp CJ, Kuhn NC, Fleming SM, Egan AE, Grant LM, Ciucci MR, MacKeigan JP, Sortwell CE. Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. Plos One. 8: e81426. PMID 24312298 DOI: 10.1371/Journal.Pone.0081426  0.806
2012 Madhavan L, Daley BF, Sortwell CE, Collier TJ. Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat. The European Journal of Neuroscience. 35: 883-95. PMID 22417168 DOI: 10.1111/J.1460-9568.2012.08019.X  0.784
2012 Gombash SE, Lipton JW, Collier TJ, Madhavan L, Steece-Collier K, Cole-Strauss A, Terpstra BT, Spieles-Engemann AL, Daley BF, Wohlgenant SL, Thompson VB, Manfredsson FP, Mandel RJ, Sortwell CE. Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 544-54. PMID 22008908 DOI: 10.1038/Mt.2011.216  0.831
2011 Spieles-Engemann AL, Steece-Collier K, Behbehani MM, Collier TJ, Wohlgenant SL, Kemp CJ, Cole-Strauss A, Levine ND, Gombash SE, Thompson VB, Lipton JW, Sortwell CE. Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. Journal of Parkinson's Disease. 1: 123-36. PMID 22328911 DOI: 10.3233/Jpd-2011-11008  0.807
2011 Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, Madhavan L, Sortwell C, Steece-Collier K, Collier TJ. Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiology of Disease. 43: 552-7. PMID 21600984 DOI: 10.1016/J.Nbd.2011.05.001  0.831
2010 Spieles-Engemann AL, Collier TJ, Sortwell CE. A functionally relevant and long-term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations. The European Journal of Neuroscience. 32: 1092-9. PMID 21039948 DOI: 10.1111/J.1460-9568.2010.07416.X  0.798
2010 Spieles-Engemann AL, Behbehani MM, Collier TJ, Wohlgenant SL, Steece-Collier K, Paumier K, Daley BF, Gombash S, Madhavan L, Mandybur GT, Lipton JW, Terpstra BT, Sortwell CE. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiology of Disease. 39: 105-15. PMID 20307668 DOI: 10.1016/J.Nbd.2010.03.009  0.825
2010 Soderstrom KE, O'Malley JA, Levine ND, Sortwell CE, Collier TJ, Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. The European Journal of Neuroscience. 31: 478-90. PMID 20105237 DOI: 10.1111/J.1460-9568.2010.07077.X  0.853
2009 Steece-Collier K, Soderstrom KE, Collier TJ, Sortwell CE, Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. The Journal of Comparative Neurology. 515: 15-30. PMID 19399877 DOI: 10.1002/Cne.22037  0.851
2008 Soderstrom KE, Meredith G, Freeman TB, McGuire SO, Collier TJ, Sortwell CE, Wu Q, Steece-Collier K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiology of Disease. 32: 229-42. PMID 18672063 DOI: 10.1016/J.Nbd.2008.06.018  0.808
2008 Lipton JW, Tolod EG, Thompson VB, Pei L, Paumier KL, Terpstra BT, Lynch KA, Collier TJ, Sortwell CE. 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology. 55: 851-9. PMID 18655796 DOI: 10.1016/J.Neuropharm.2008.06.062  0.821
2008 McGuire SO, Counts SE, Lum H, Sortwell CE, Daley BF, Collier TJ. cAMP pretreatment increases the number of dopamine neurons in intrastriatal grafts Journal of Neurochemistry. 81: 112-112. DOI: 10.1046/j.1471-4159.81.s1.43_2.x  0.786
2007 Terpstra BT, Collier TJ, Marchionini DM, Levine ND, Paumier KL, Sortwell CE. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. Journal of Neuroscience Methods. 166: 13-9. PMID 17706789 DOI: 10.1016/J.Jneumeth.2007.06.022  0.818
2007 Marchionini DM, Lehrmann E, Chu Y, He B, Sortwell CE, Becker KG, Freed WJ, Kordower JH, Collier TJ. Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Research. 1147: 77-88. PMID 17368428 DOI: 10.1016/J.Brainres.2007.02.028  0.784
2007 Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR, Kordower JH. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiology of Disease. 26: 56-65. PMID 17254792 DOI: 10.1016/J.Nbd.2006.11.013  0.825
2007 Sortwell CE, Bowers WJ, Counts SE, Pitzer MR, Fleming MF, McGuire SO, Maguire-Zeiss KA, Federoff HJ, Collier TJ. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Research. 1134: 33-44. PMID 17196186 DOI: 10.1016/J.Brainres.2006.11.079  0.779
2006 McGuire SO, Sortwell CE, Shukitt-Hale B, Joseph JA, Hejna MJ, Collier TJ. Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons. Nutritional Neuroscience. 9: 251-8. PMID 17263092 DOI: 10.1080/10284150601086134  0.79
2006 Kordower JH, Kanaan NM, Chu Y, Suresh Babu R, Stansell J, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Annals of Neurology. 60: 264-8. PMID 16862579 DOI: 10.1002/Ana.20935  0.821
2006 Kanaan NM, Collier TJ, Marchionini DM, McGuire SO, Fleming MF, Sortwell CE. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Research. 1068: 221-9. PMID 16368081 DOI: 10.1016/J.Brainres.2005.10.078  0.856
2006 Maries E, Kordower JH, Chu Y, Collier TJ, Sortwell CE, Olaru E, Shannon K, Steece-Collier K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiology of Disease. 21: 165-80. PMID 16095907 DOI: 10.1016/J.Nbd.2005.07.002  0.844
2006 Terpstra B, Collier T, Kanaan N, Levine N, Wohlgenant S, Kordower J, Sortwell C. Re-evaluation of systemic proteasome inhibition as an animal model for Parkinson's disease Experimental Neurology. 198: 590-591. DOI: 10.1016/J.Expneurol.2006.02.096  0.795
2006 Soderstrom K, Levine N, Sortwell C, Collier T, Steece-Collier K. The role of the immune response in the development of dyskinesias following allografting in rats Experimental Neurology. 198: 590. DOI: 10.1016/J.Expneurol.2006.02.095  0.781
2006 Paumier K, Sortwell C, Daley B, Johe K, Collier T. Midbrain derived human progenitor cells provide neuroprotection when grafted adjacent to rat substantia nigra Experimental Neurology. 198: 585. DOI: 10.1016/j.expneurol.2006.02.083  0.817
2006 Lipton J, Paumier K, Sortwell C, Campbell N, Choi D, Collier T. Fetal mesencephalic cells exposed to MDMA (Ecstasy) enhance dopamine cell survival and neurite outgrowth in vitro Experimental Neurology. 198: 577-578. DOI: 10.1016/J.Expneurol.2006.02.064  0.801
2006 Choi D, Paumier K, Sortwell C, Campbell N, Collier T, Lipton J. Fetal mesencephalic cells exposed to MDMA (ecstasy) enhance dopamine cell survival and neurite outgrowth in vitro Experimental Neurology. 198: 564-565. DOI: 10.1016/j.expneurol.2006.02.032  0.805
2004 Marchionini DM, Collier TJ, Pitzer MR, Sortwell CE. Reassessment of caspase inhibition to augment grafted dopamine neuron survival. Cell Transplantation. 13: 273-82. PMID 15191165  0.777
2004 Sortwell CE, Collier TJ, Camargo MD, Pitzer MR. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality. Experimental Neurology. 187: 58-64. PMID 15081588 DOI: 10.1016/j.expneurol.2003.12.008  0.775
2003 Marchionini DM, Collier TJ, Camargo M, McGuire S, Pitzer M, Sortwell CE. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. The Journal of Comparative Neurology. 464: 172-9. PMID 12898610 DOI: 10.1002/cne.10785  0.78
2003 Pitzer MR, Sortwell CE, Daley BF, McGuire SO, Marchionini D, Fleming M, Collier TJ. Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Experimental Neurology. 182: 435-45. PMID 12895454 DOI: 10.1016/S0014-4886(03)00100-6  0.775
2003 Collier TJ, Steece-Collier K, McGuire S, Sortwell CE. Cellular models to study dopaminergic injury responses. Annals of the New York Academy of Sciences. 991: 140-51. PMID 12846983  0.834
2003 Sortwell CE. Strategies for the augmentation of grafted dopamine neuron survival. Frontiers in Bioscience : a Journal and Virtual Library. 8: s522-32. PMID 12700087  0.315
2002 Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, Mufson EJ. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. Journal of Neurochemistry. 83: 442-51. PMID 12423254 DOI: 10.1046/j.1471-4159.2002.01148.x  0.767
2002 Collier TJ, Sortwell CE, Elsworth JD, Taylor JR, Roth RH, Sladek JR, Redmond DE. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. The Journal of Comparative Neurology. 442: 320-30. PMID 11793337 DOI: 10.1002/Cne.10108  0.841
2001 Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Experimental Neurology. 171: 98-108. PMID 11520124 DOI: 10.1006/Exnr.2001.7735  0.804
2001 McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Experimental Neurology. 169: 219-30. PMID 11358437 DOI: 10.1006/Exnr.2001.7688  0.842
2001 Sortwell CE, Camargo MD, Pitzer MR, Gyawali S, Collier TJ. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Experimental Neurology. 169: 23-9. PMID 11312554 DOI: 10.1006/exnr.2001.7644  0.794
2000 Kordower JH, Sortwell CE. Neuropathology of fetal nigra transplants for Parkinson's disease. Progress in Brain Research. 127: 333-44. PMID 11142034 DOI: 10.1016/S0079-6123(00)27016-7  0.417
2000 Sortwell CE, Pitzer MR, Collier TJ. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Experimental Neurology. 165: 268-77. PMID 10993687 DOI: 10.1006/exnr.2000.7476  0.772
2000 Sortwell CE, Daley BF, Pitzer MR, McGuire SO, Sladek JR, Collier TJ. Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death. The Journal of Comparative Neurology. 426: 143-53. PMID 10980489 DOI: 10.1002/1096-9861(20001009)426:1<143::AID-CNE10>3.0.CO;2-8  0.836
2000 Sortwell CE, Daley BF, Pitzer MR, McGuire SO, Sladek JR, Collier TJ. Calretinin expression in specific neuronal systems in the brain of an advanced teleost, the grey mullet (Chelon labrosus) Journal of Comparative Neurology. 426: 81-105. PMID 10980485 DOI: 10.1002/1096-9861(20001009)426:1<81::AID-CNE6>3.0.CO;2-E  0.776
2000 Leventhal L, Sortwell CE, Hanbury R, Collier TJ, Kordower JH, Palfi S. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. The Journal of Comparative Neurology. 425: 471-8. PMID 10975874 DOI: 10.1002/1096-9861(20001002)425:4<471::Aid-Cne1>3.0.Co;2-U  0.778
2000 Ling ZD, Collier TJ, Sortwell CE, Lipton JW, Vu TQ, Robie HC, Carvey PM. Striatal trophic activity is reduced in the aged rat brain. Brain Research. 856: 301-9. PMID 10677639 DOI: 10.1016/S0006-8993(00)01945-4  0.82
1999 Collier TJ, Sortwell CE, Daley BF. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5563-73. PMID 10377363  0.799
1999 Collier TJ, Sortwell CE. Therapeutic potential of nerve growth factors in Parkinson's disease. Drugs & Aging. 14: 261-87. PMID 10319241 DOI: 10.2165/00002512-199914040-00003  0.792
1998 Sortwell CE, Collier TJ, Sladek JR. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons. The Journal of Comparative Neurology. 399: 530-40. PMID 9741481 DOI: 10.1002/(SICI)1096-9861(19981005)399:4<530::AID-CNE6>3.0.CO;2-2  0.836
1998 Sortwell CE, Blanchard BC, Collier TJ, Elsworth JD, Taylor JR, Roth RH, Redmond DE, Sladek JR. Pattern of synaptophysin immunoreactivity within mesencephalic grafts following transplantation in a parkinsonian primate model. Brain Research. 791: 117-24. PMID 9593853 DOI: 10.1016/S0006-8993(98)00086-9  0.81
1997 Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplantation. 6: 309-15. PMID 9171163 DOI: 10.1016/S0963-6897(97)00031-6  0.824
1995 Sortwell CE, Pappas GD, Sagen J. Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test. Experimental Brain Research. 103: 59-69. PMID 7615038 DOI: 10.1007/Bf00241965  0.526
1995 Dougherty DD, Sortwell CE, Sagen J. Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants. Psychopharmacology. 118: 10-8. PMID 7597115 DOI: 10.1007/BF02245244  0.494
1994 Sortwell CE, Petty F, Kramer G, Sagen J. In vivo release of catecholamines from xenogeneic chromaffin cell grafts with antidepressive activity. Experimental Neurology. 130: 1-8. PMID 7821384 DOI: 10.1006/Exnr.1994.1178  0.563
1993 Sortwell CE, Sagen J. Induction of antidepressive activity by monoaminergic transplants in rat neocortex. Pharmacology, Biochemistry, and Behavior. 46: 225-30. PMID 8255915 DOI: 10.1016/0091-3057(93)90345-T  0.516
1992 Sortwell CE, Sagen J. Behavioral and biochemical assessment of monoaminergic neural transplants to rat frontal neocortex Journal of Neural Transplantation and Plasticity. 3: 307-308. DOI: 10.1155/Np.1992.307  0.494
1990 Sagen J, Sortwell CE, Pappas GD. Monoaminergic neural transplants prevent learned helplessness in a rat depression model. Biological Psychiatry. 28: 1037-48. PMID 1963093 DOI: 10.1016/0006-3223(90)90604-Z  0.496
Show low-probability matches.